FDA Priority Review for Pfizer investigational leukaemia drug
February 22, 2017Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review
Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …
FDA rejects Amphastar’s application for NDA for intranasal overdose treatment
February 21, 2017Research and Development Amphastar, FDA
Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …
Anti-aging study reveals role of mitochondria pointing towards new medicine
February 21, 2017Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria
A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …
NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx
February 21, 2017Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen
NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …
Faulty batch of Takeda’s paracetamol discovered in Denmark
February 21, 2017Manufacturing and Production Denmark, Takeda
Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …
Merck eyes new India bio-production facility
February 21, 2017Manufacturing and Production Merck
German pharmaceutical firm Merck has made it known that it has plans to expand its operations in India with a …
Amygdala acquires Gilead’s candidate for addiction treatment
February 20, 2017Manufacturing and Production, Sales and Marketing Amygdala, Gilead
Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …
BlackThorn Therapeutics bring in new CEO
February 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics
BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
Generic version of top-selling lung cancer drug hits Chinese market
February 20, 2017Sales and Marketing China, generics
A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …
Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis
February 20, 2017Research and Development, Sales and Marketing Celgene, multiple sclerosis
Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
Cardiovascular disease expected to place $1 trillion cost burden on US
February 20, 2017Medical Communications, Sales and Marketing cardiovascular disease
A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …
AstraZeneca sells off cancer drug to TerSera for $250 million
February 20, 2017Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex
AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …
Rise of superbugs in hospitals down to cutting cleaners’ jobs, suggests GMB
February 20, 2017Sales and Marketing GMB, MRSA, NHS, Superbugs
The rising numbers in those exposed to superbugs, such as E.coli and MRSA, is due to the cuts in the …
New Managing Director of UK & Ireland for Novartis
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis
Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …
Top Ten most popular articles on Pharmafile.com this week
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
The future of generic drugs and strategies for commercial success
February 17, 2017Medical Communications generics
GBI Research examines whether the US continue to dominate the global generic drug market.
Zydus Cadila scores twin FDA approvals
February 17, 2017Medical Communications, Sales and Marketing FDA, Zydus Cadila
Indian pharmaceutical firm Zydus Cadila has announced that the US Food and Drug Administration (FDA) has given the go-ahead for …
AstraZeneca’s drug scores positive results against chemo in breast cancer
February 17, 2017Medical Communications, Research and Development AstraZeneca
AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …
Takeda and TiGenix announce successful trial of Crohn’s disease drug
February 17, 2017Medical Communications, Sales and Marketing Takeda, TiGenix
Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601, a treatment for refractory …
What does Trump’s victory mean for the pharma, biotech and healthcare sectors?
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump
After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …
